How Worldwide Flex Stabilized A Biotech Sponsor's Data Management And Biostatistics Functions

Mid-study transitions are notoriously risky, but allowing persistent data quality issues to compound poses a far greater threat to clinical program integrity. When an active study faced deteriorating clean-up cadences under an academic CRO, the sponsor took decisive action. Successfully rescuing a compromised study without disrupting operational momentum demands immediate mobilization, surgical precision, and absolute system control.
By assuming full administrative rights over the EDC platform and executing a disciplined remediation strategy, the rescue team deployed rigorous access controls alongside robust edit checks and manual review protocols. This swift intervention stabilized the data environment, cleared systemic bottlenecks, and ultimately delivered an interim database lock within the first year. Read the complete story to discover how a collaborative, agile approach can protect your vital trial timelines and safeguard data integrity under pressure.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.